We reviewed our center's experience with nightly automated peritoneal
dialysis (APD) as maintenance renal replacement therapy (RRT) for infa
nts and children under the age of 5 years and compared it with nationa
l dialysis and transplant data, A retrospective chart review of 19 con
secutive patients with the onset of endstage renal disease (ESRD) befo
re 5 years of age (mean = 1.8 years) between June 1988 and June 1994 w
as performed. All patients received nightly APD, supplemental feedings
, calcitriol, erythropoietin, and 10 of 19 were on growth hormone (rhG
H) therapy. The growth of our patients was maintained or improved duri
ng the study period, with the 10 of 19 on rhGH gaining a mean of one s
tandard deviation in height when followed for 2 years. Our school-age
children were all in age-appropriate classes. There were no deaths in
our group; the incidence of peritonitis was lower than in national dat
a. We conclude that APD is a realistic option for the treatment of ESR
D in the 0- to 5-year-old child. Because of the improved graft and pat
ient survival in older children, APD in a specialized center might be
the RRT of choice in this age group, allowing good growth and developm
ent while maximizing the chances of an eventual and successful renal t
ransplant.